Who
Andrew Dreyfus
Director
Company insider
Files Form 4 as: Director, Alto Neuroscience; Director, Ironwood Pharmaceuticals.
In numbers
- Trades disclosed
- 26
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 6 Apr 2016
- Last trade
- 12 May 2026
- Last filed
- 14 May 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 May 2026filed 14 May 2026 | ANRO Alto Neuroscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,958 at $0.00 | filing |
| 12 May 2026filed 14 May 2026 | ANRO Alto Neuroscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,958 at $0.00 | filing |
| 10 Jun 2025filed 12 Jun 2025 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 13 May 2025filed 15 May 2025 | ANRO Alto Neuroscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,287 at $0.00 | filing |
| 18 Jun 2024filed 21 Jun 2024 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —24,311 at $0.00 | filing |
| 1 Feb 2024filed 5 Feb 2024 | ANRO Alto Neuroscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,574 at $0.00 | filing |
| 20 Jun 2023filed 22 Jun 2023 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —22,350 at $0.00 | filing |
| 1 Jun 2022filed 3 Jun 2022 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —21,571 at $0.00 | filing |
| 15 Dec 2021filed 17 Dec 2021 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —1,431 at $0.00 | filing |
| 15 Sep 2021filed 17 Sep 2021 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —1,344 at $0.00 | filing |
| 15 Jun 2021filed 16 Jun 2021 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —1,453 at $0.00 | filing |
| 2 Jun 2021filed 4 Jun 2021 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —22,766 at $0.00 | filing |
| 15 Mar 2021filed 17 Mar 2021 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —1,460 at $0.00 | filing |
| 15 Dec 2020filed 17 Dec 2020 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —1,357 at $0.00 | filing |
| 15 Sep 2020filed 17 Sep 2020 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —1,600 at $0.00 | filing |
| 15 Jun 2020filed 16 Jun 2020 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —1,745 at $0.00 | filing |
| 3 Jun 2020filed 5 Jun 2020 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —21,720 at $0.00 | filing |
| 13 Mar 2020filed 17 Mar 2020 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —1,596 at $0.00 | filing |
| 13 Dec 2019filed 17 Dec 2019 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —1,270 at $0.00 | filing |
| 13 Sep 2019filed 16 Sep 2019 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —1,692 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.